| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ONCOSEC MEDICAL Inc | VP, Finance | Common Stock | 1.01K | $1.38K | $1.37 | 09 Feb 2023 | Direct |
| Grace Therapeutics, Inc. | Principal Financial Officer | Stock Option (Right to Buy) | 20.1K | 14 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | 14 Apr 2025 | 1 | $0 | 4 | Principal Financial Officer | 16 Apr 2025, 20:58 |
| ACST | Acasti Pharma Inc. | 06 May 2024 | 1 | $0 | 4 | Principal Financial Officer | 08 May 2024, 19:18 |
| ACST | Acasti Pharma Inc. | 05 Jan 2024 | 0 | $0 | 3 | Vice President, Finance | 08 Jan 2024, 08:00 |
| ONCS | ONCOSEC MEDICAL Inc | 09 Feb 2023 | 1 | -$55 | 4 | VP, Finance | 09 Feb 2023, 19:11 |
| ONCS | ONCOSEC MEDICAL Inc | 04 Nov 2022 | 1 | -$105 | 4 | VP, Finance | 04 Nov 2022, 20:21 |
| ONCS | ONCOSEC MEDICAL Inc | 05 Aug 2022 | 1 | -$202 | 4 | VP, Finance | 05 Aug 2022, 20:00 |
| ONCS | ONCOSEC MEDICAL Inc | 06 May 2022 | 1 | -$227 | 4 | VP, Finance | 06 May 2022, 12:35 |
| ONCS | ONCOSEC MEDICAL Inc | 09 Feb 2022 | 1 | -$360 | 4 | VP, Finance | 11 Feb 2022, 19:00 |
| ONCS | ONCOSEC MEDICAL Inc | 01 Nov 2021 | 1 | -$600 | 4 | VP, Finance | 03 Nov 2021, 20:00 |
| ONCS | ONCOSEC MEDICAL Inc | 01 Aug 2021 | 1 | -$898 | 4 | VP, Finance | 03 Aug 2021, 20:14 |
| ONCS | ONCOSEC MEDICAL Inc | 28 Jun 2021 | 1 | $0 | 4 | Vice President, Finance | 29 Jun 2021, 19:43 |